These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 15456956

  • 1. Posttransplant lymphoma--a single-center experience of 500 liver transplantations.
    Norin S, Kimby E, Ericzon BG, Christensson B, Sander B, Söderdahl G, Hägglund H.
    Med Oncol; 2004; 21(3):273-84. PubMed ID: 15456956
    [Abstract] [Full Text] [Related]

  • 2. Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
    Mumtaz K, Faisal N, Marquez M, Healey A, Lilly LB, Renner EL.
    Can J Gastroenterol Hepatol; 2015; 29(8):417-22. PubMed ID: 26076399
    [Abstract] [Full Text] [Related]

  • 3. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [Abstract] [Full Text] [Related]

  • 4. Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
    Patel H, Vogl DT, Aqui N, Shaked A, Olthoff K, Markmann J, Reddy R, Stadtmauer EA, Schuster S, Tsai DE.
    Leuk Lymphoma; 2007 May; 48(5):885-91. PubMed ID: 17487731
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.
    Berney T, Delis S, Kato T, Nishida S, Mittal NK, Madariaga J, Levi D, Nery JR, Cirocco RE, Gelman B, Ruiz P, Tzakis AG.
    Transplantation; 2002 Oct 15; 74(7):1000-6. PubMed ID: 12394845
    [Abstract] [Full Text] [Related]

  • 6. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
    Mamzer-Bruneel MF, Lomé C, Morelon E, Levy V, Bourquelot P, Jacobs F, Gessain A, Mac Intyre E, Brousse N, Kreis H, Hermine O.
    J Clin Oncol; 2000 Nov 01; 18(21):3622-32. PubMed ID: 11054435
    [Abstract] [Full Text] [Related]

  • 7. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H, Reinke P, Neuhaus R, Lehmkuhl H, Oertel S, Atta J, Planker M, Gärtner B, Lenze D, Anagnostopoulos I, Riess H, Trappe RU.
    Cancer; 2012 Oct 01; 118(19):4715-24. PubMed ID: 22392525
    [Abstract] [Full Text] [Related]

  • 8. Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.
    Serinet MO, Jacquemin E, Habes D, Debray D, Fabre M, Bernard O.
    J Pediatr Gastroenterol Nutr; 2002 Apr 01; 34(4):389-93. PubMed ID: 11930095
    [Abstract] [Full Text] [Related]

  • 9. Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.
    Sprangers B, Riella LV, Dierickx D.
    Am J Kidney Dis; 2021 Aug 01; 78(2):272-281. PubMed ID: 33774079
    [Abstract] [Full Text] [Related]

  • 10. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S, German PTLD Study Group, European PTLD Network.
    Lancet Oncol; 2012 Feb 01; 13(2):196-206. PubMed ID: 22173060
    [Abstract] [Full Text] [Related]

  • 11. EBV and posttransplantation lymphoproliferative disease: what to do?
    Zimmermann H, Trappe RU.
    Hematology Am Soc Hematol Educ Program; 2013 Feb 01; 2013():95-102. PubMed ID: 24319169
    [Abstract] [Full Text] [Related]

  • 12. Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab.
    Alexandru S, Gonzalez E, Grande C, Hernandez A, Morales E, Praga M, Andres A, Morales JM.
    Transplant Proc; 2009 Feb 01; 41(6):2435-7. PubMed ID: 19715944
    [Abstract] [Full Text] [Related]

  • 13. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S.
    Transplantation; 2007 Apr 15; 83(7):912-8. PubMed ID: 17460562
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
    Kuriyama T, Kawano N, Yamashita K, Ueda A.
    J Clin Exp Hematop; 2014 Apr 15; 54(2):149-53. PubMed ID: 25318948
    [Abstract] [Full Text] [Related]

  • 15. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation.
    Yedibela S, Reck T, Niedobitek G, Gramatzki M, Repp R, Hohenberger W, Ott R.
    Transpl Int; 2003 Mar 15; 16(3):197-201. PubMed ID: 12664216
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.
    Pathol Res Pract; 2013 Aug 15; 209(8):471-8. PubMed ID: 23726928
    [Abstract] [Full Text] [Related]

  • 18. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
    Transplant Proc; 2010 Jun 15; 42(5):1763-8. PubMed ID: 20620519
    [Abstract] [Full Text] [Related]

  • 19. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 15; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA, Broxson EH, Dole MG, Filippa DA, George D, Lyden D, Dunkel IJ.
    J Pediatr Hematol Oncol; 2002 Feb 15; 24(2):160-3. PubMed ID: 11998794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.